Published in Gene Therapy Weekly, April 21st, 1997
Cortecs' basic drug delivery research has led to the discovery of a group of novel, natural molecules that have anti-cancer activity (Cellcom). In work carried out with the CRC Centre for Cancer Therapeutics at the Institute for Cancer Research at The Royal Marsdan Hospital, Cortecs has shown that these novel molecules display anti-tumor activity against several human cancers in vitro, including ovarian, lung, colon, breast, and melanoma cell lines. In vivo...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.